X4 Pharmaceuticals, Inc
XFOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501697
In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 2 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding X4 Pharmaceuticals, Inc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 90 | 1 | 94 | +5 |
| Shares | 99.8M | 20.0K | 98.6M | −1.20M (−1.2%) |
| Value | $73.2M | $14.7K | $23.3M | −$49.9M (−68.2%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 67,305 | $16.0K | 0.00% |
| CIBC Private Wealth Group, LLC | 64,988 | $13.8K | 0.00% |
| Intech Investment Management LLC | 57,960 | $13.7K | 0.00% |
| XTX Topco Ltd | 57,803 | $13.7K | 0.00% |
| Neuberger Berman Group LLC | 44,667 | $10.6K | 0.00% |
| HRT Financial LP | 34,482 | $8.00K | 0.00% |
| Mariner, LLC | 20,267 | $4.79K | 0.00% |
| Renaissance Technologies LLC | 20,100 | $4.75K | 0.00% |
| Wealthcare Capital Partners, LLC | 17,845 | $4.22K | 0.00% |
| Claudia M.P. Batlle, CRP (R) LLC | 15,063 | $3.56K | 0.00% |
| GTS Securities LLC | 12,668 | $2.99K | 0.00% |
| Allred Capital Management, LLC | 11,560 | $2.73K | 0.00% |
| Jones Financial Companies LLLP | 1,144 | $286 | 0.00% |
| GWM Advisors LLC | 1,000 | $236 | 0.00% |
| CIBC World Markets Inc. | 35,000 | – | – |
Sold out (10)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Gsa Capital Partners LLP | 1,273,635 | $934.0K |
| Jane Street Group, LLC | 583,483 | $428.0K |
| Knott David M Jr | 154,071 | $113.0K |
| Vontobel Holding Ltd. | 75,000 | $55.0K |
| Atria Wealth Solutions, Inc. | 60,000 | $44.0K |
| Wolverine Trading, LLC | 39,663 | $32.1K |
| Integrated Wealth Concepts LLC | 30,000 | $22.0K |
| LPL Financial LLC | 11,500 | $8.44K |
| Nisa Investment Advisors, LLC | 919 | $674 |
| Clearstead Advisors, LLC | 100 | $74 |
Not filed for Q1 2025 yet (1)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Cassady Schiller Wealth Management, LLC | 20,000 | $14.7K |